Richard P. Church

Richard P. Church
K&L Gates
Partner
919-466-1187
Website
www.klgates.com
Organization Profile Full Profile
Connect
- Email

Professional Biography:

Richard Church is a co-leader of the firm’s national health care practice group. He focuses his practice on health law regulatory issues and health care joint ventures, clinical integration and mergers and acquisitions. Richard handles complex 340B structuring, enrollment and compliance matters, Medicare and Medicaid enrollment and reimbursement issues, and health care operational matters. He also handles complex affiliations and transactions between health care providers, including legal compliance, change of ownership filings, and development of post-transaction reimbursement structures. He has been listed in Chambers USA since 2014 for Healthcare – North Carolina.

Articles in the National Law Review database by Richard P. Church

2022 OPPS Final Rule Overview: CMS Finalizes Policies on 340B, Hospital Price Transparency, and Inpatient-Only List (Posted On Monday, November 8, 2021)
What Health Care Providers Should Expect in an FDA Inspection [PODCAST] (Posted On Thursday, October 28, 2021)
CMS Proposes to Rescind Most Favored Nation Drug Pricing Rule (Posted On Tuesday, August 10, 2021)
CMS Proposes to Increase Penalties for Hospital Price Transparency Noncompliance (Posted On Thursday, July 22, 2021)
When Regulatory Review Is Necessary: Clinical Research vs. Quality Initiatives [PODCAST] (Posted On Friday, July 16, 2021)
HHS Opens Provider Relief Fund Reporting Portal with New Guidance on Reporting Requirements (Posted On Friday, July 9, 2021)
340B Update: Supreme Court Accepts Certiorari in 340B Payment Reduction Case (Posted On Thursday, July 8, 2021)
340B Update: Delaware Court Denies 340B Program Statute Requiring Contract Pharmacy Arrangements (Posted On Wednesday, July 7, 2021)
COVID-19: Biden Administration Issues First Major Update to Provider Relief Fund Requirements: Reporting Portal Opens 1 July 2021 (Posted On Tuesday, June 15, 2021)
Understanding OIG and CMS Audits [Podcast] (Posted On Thursday, June 10, 2021)
The Power of Health Care: Renewable Energy Transactions from the Health Care Perspective [PODCAST] (Posted On Thursday, June 3, 2021)
340B Update: HRSA Issues Final Warning Letter to Pharmaceutical Manufacturers that Their Contract Pharmacy Actions Violate 340B Statute (Posted On Wednesday, May 26, 2021)
Health Care Audit and Reimbursement Trends and Challenges [PODCAST] (Posted On Thursday, April 29, 2021)
340B Update: Federal Court Halts 340B Administrative Dispute Resolution Rule (Posted On Monday, March 29, 2021)
Hospitals Ask Supreme Court to Reverse Site-Neutral, 340B Payment Rulings (Posted On Thursday, March 25, 2021)
340B Drug Pricing Program 2021 Outlook [PODCAST] (Posted On Friday, March 19, 2021)
What to Expect in Health Care in 2021 [PODCAST] (Posted On Friday, February 26, 2021)
COVID-19 Provider Relief Funds: What to Expect as Reporting Begins in 2021 (Posted On Tuesday, January 19, 2021)
Federal Courts Block Implementation of Most Favored Nation Drug Pricing Rule (Posted On Tuesday, December 29, 2020)
340b Update: Recent Supreme Court Ruling May Curtail 340b Program Discriminatory Pricing (Posted On Tuesday, December 22, 2020)

Pages

Healthcare Law

340 B Drug Pricing Program

Richard P. Church is a National Law Review Go-To Thought Leader for his ongoing coverage and analysis of healthcare compliance issues, the regulation of drug prices and the 340 B Drug Reimbursement program. Mr. Church’s extensive experience with state and federal fraud compliance and Medicare/Medicaid reimbursement issues really shows when he interprets the implications of executive orders and the flurry of last minute healthcare regulatory changes from the outgoing Trump administration.